CompanyDeals

Nona Biosciences Partners with Mythic Therapeutics for Next-Gen ADCs

CompanyDrug

Everest Medicines’ Nefecon Included in South Korea’s GIFT Program

CompanyDeals

Haohai Bio Acquires Additional Stake in SZNIMO for Ophthalmic Expansion

CompanyDrug

Hinova’s HP530S Accepted for NMPA Review as FAK Inhibitor for Solid Tumors

Company

AstraZeneca Reports Q4 and Full-Year 2022 Results with Strong Revenue Growth

CompanyDrug

Qilu Pharmaceutical’s QLS12004 Gains Tacit Clinical Trial Approval

CompanyDeals

Sino Biopharmaceutical Terminates IPO Pre-Listing Process for STAR Board

CompanyDeals

Shanghai Pinnacles Partners with Sysmex for Biochemical Immune Diagnosis Solutions

CompanyDeals

GenScript ProBio Partners with Bio Immunitas for hRPP Platform

CompanyDrug

ImmVira’s MVR-T3011 IT Shows Efficacy in Melanoma Treatment

CompanyDeals

Hemay Pharma Completes Series D Financing for Autoimmune and Oncology Drugs

CompanyDeals

Neurodawn Completes Series A+ Financing for CNS Drug Development